Centhaquine set to enter US-FDA approved Phase 3 clinical trial in US and Europe EP News Bureau Aug 2, 2023 Pharmazz India obtained marketing authorization for the management of Hypovolemic shock Lyfaquin (INN: Centhaquine) in India in…
EMA accepts Intas Pharma’s MAA for DMB-3115 EP News Bureau Jul 14, 2023 herapeutic equivalence and safety confirmed between DMB-3115 and Stelara in global phase III
